OTCMKTS:NUMIF Numinus Wellness (NUMIF) Stock Price, News & Analysis → The only financial event in 2024 that matters (From Porter & Company) (Ad) Free NUMIF Stock Alerts C$0.05 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share Today's RangeC$0.05▼C$0.0550-Day RangeC$0.05▼C$0.0952-Week RangeC$0.04▼C$0.20Volume239,603 shsAverage Volume262,051 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Numinus Wellness alerts: Email Address Ad Wealthpin ProDo This Before July 30 2024 To Claim Trump’s Gift In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. About Numinus Wellness Stock (OTCMKTS:NUMIF)Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States. The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments. The Clinical Research Operations segment offers clinical research management services to academic institutions and biotechnology companies. The Canadian Clinic Network segment provides clinical services, including traditional therapy and counseling, ketamine-assisted therapies for depression, psychedelic-assisted therapies, mindfulness programs, and virtual psychotherapy services, as well as neurological care services. The US clinic network segment offers psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management services. The company also offers laboratory services, such as the cultivation, production, and extraction of natural Psilocybe and other psychoactive fungi species, the development of proprietary processes and products, methods for controlled psychedelics and development of a pipeline for product development, and protocol development and safety and efficacy studies; lab testing services; and psychedelic-assisted therapy training services. The company was incorporated in 1964 and is headquartered in Vancouver, Canada.Read More NUMIF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NUMIF Stock News HeadlinesMay 31 at 7:38 PM | prnewswire.comNuminus Wellness Announces Voting Results From its Annual General Meeting of ShareholdersMay 30 at 7:00 AM | prnewswire.comNuminus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted TherapyMay 7, 2024 | prnewswire.comNuminus Wellness Focused on Boosting Profitability and Expanding Community SupportApril 18, 2024 | uk.investing.comEarnings call: Numinus Wellness reports Q2 fiscal 2024 resultsApril 17, 2024 | finanznachrichten.deNuminus Wellness Inc.: Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003April 17, 2024 | finance.yahoo.comCedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003April 15, 2024 | benzinga.comNuminus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry TrendsApril 15, 2024 | marketwatch.comNuminus Wellness Shares Down on Canadian Operations ReorganizationApril 15, 2024 | prnewswire.comNuminus Wellness Provides Corporate UpdateApril 12, 2024 | prnewswire.comNuminus Wellness Inc. Announces Second Quarter Fiscal 2024 ResultsApril 9, 2024 | prnewswire.comNuminus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024April 2, 2024 | msn.comOnconova slips after all-stock merger with TrawsfynyddMarch 28, 2024 | ca.finance.yahoo.comTrump Media Goes Public Via SPAC DealMarch 26, 2024 | finance.yahoo.comPharmAla Biotech Signs Sale Agreement with NuminusMarch 26, 2024 | msn.comPharmAla Biotech signs sale agreement with Numinus WellnessMarch 20, 2024 | prnewswire.comNuminus Wellness Submits Clinical Trial ApplicationMarch 12, 2024 | finanznachrichten.deNuminus Wellness Inc.: Numinus Wellness Provides Corporate UpdateMarch 12, 2024 | prnewswire.comNuminus Wellness Provides Corporate UpdateMarch 1, 2024 | seekingalpha.comNUMIF Numinus Wellness Inc.February 23, 2024 | msn.comNuminus CEO Reflects On Monumental Achievement: FDA's Acceptance Of MDMA Therapy ApplicationFebruary 16, 2024 | theglobeandmail.comThis May be One of the Biggest Catalysts for Psychedelic Stocks in 2024February 16, 2024 | finance.yahoo.comNuminus Wellness Inc. Closes $6 Million Bought Deal Public OfferingFebruary 1, 2024 | finance.yahoo.comNuminus Wellness Inc. Announces $6 Million Bought Deal Public Offering with Leads Orders from MAPS and Integrated V.C.February 1, 2024 | finance.yahoo.comNuminus Wellness Divests of Holdings in Alto Neuroscience Inc.January 18, 2024 | msn.comNuminus Wellness Continues Tight Expense Management With Strategic Reviews UnderwaySee More Headlines Receive NUMIF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Numinus Wellness and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolOTCMKTS:NUMIF CUSIPN/A CIKN/A Webwww.numinus.com Phone(604) 649-3229FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Payton NyquvestFounder, CEO & ChairmanMr. Michael Tan M.B.A.President, COO & DirectorDr. Paul Thielking M.D.Chief Science & Medical OfficerDr. Reid J. Robison M.D. (Age 47)MBA, Chief Clinical Officer Comp: $396.2kMs. Melony Valleau CPA (Age 55)Interim Chief Financial Officer Jamie KokoskaVice President of Investor RelationsMs. Paula Amy Hewitt (Age 51)Senior VP, General Counsel & Chief Privacy Officer Mr. Ian NobleChief Communications OfficerMs. Danielle HinanVice President MarketingMs. Lea BottoniVice President of People & CultureMore ExecutivesKey CompetitorsAmerican Oncology NetworkNASDAQ:AONCWAmerican Oncology NetworkNASDAQ:AONCBangkok Dusit Medical Services PublicOTCMKTS:BDULFBumrungrad Hospital PublicOTCMKTS:BUHPFCareRxOTCMKTS:CHHHFView All Competitors NUMIF Stock Analysis - Frequently Asked Questions How have NUMIF shares performed in 2024? Numinus Wellness' stock was trading at C$0.08 at the beginning of 2024. Since then, NUMIF stock has decreased by 40.9% and is now trading at C$0.05. View the best growth stocks for 2024 here. Are investors shorting Numinus Wellness? Numinus Wellness saw a increase in short interest in April. As of April 30th, there was short interest totaling 1,062,300 shares, an increase of 63.1% from the April 15th total of 651,500 shares. Based on an average daily volume of 370,700 shares, the days-to-cover ratio is presently 2.9 days. View Numinus Wellness' Short Interest. How do I buy shares of Numinus Wellness? Shares of NUMIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:NUMIF) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Numinus Wellness Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.